Potential Drug Interaction Between ALXN2040 and Rosuvastatin
Clinical trial NCT05708573 · COMPLETED
Trial details
- NCT number
- NCT05708573
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-03-23
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.